MedPath

ADRED – Adverse drug reactions (ADR) leading to emergency department (ED) visits: Causality analysis and preventability rate of the ADRs

Recruiting
Conditions
Y57
T88.0
Other and unspecified drugs and medicaments
Infection following immunization
Registration Number
DRKS00008979
Lead Sponsor
Forschungsabteilung BfArM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
9000
Inclusion Criteria

Patients with adverse drug reactions (ADRs), which needed a treatment in an emergency department. In these cases, it comes to enrollment after positive causality assessment of ADRs by the physician.
Age =18 years.
Capacity to consent and written informed consent of the patient.

Exclusion Criteria

Patients treated in the emergency center without UAW by using home medication. (after causality assessment by a health professional in the emergency room).
Intentional ingestion of inappropriate drugs or doses, by the patients themselves, which have led to the adverse effect (eg. As with suicidal intent).
Age <18 years

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary target is the occurrence of at least one avoidable ADRs (Adverse Drug Reaction) per patient, which have led to hospital emergency treatment.<br><br>The classification of ADRs as avoidable (medication errors) is being edited with a work of score called Schumock et al. (1992). <br>
Secondary Outcome Measures
NameTimeMethod
1) Possible causes of preventable ADRs, which have led to hospital emergency treatment:<br>Medication errors types and causes (eg. As dose omission, incorrect application form, wrong patient et cetera.)<br><br>2) Possible causes of non-preventable ADRs, which have led to hospital emergency treatment:<br>• Patient-related factors (gender, age, comorbidity et cetera.)<br>• Pharmacogenetic causes of ADRs<br><br>3) consequences of ADRs:<br>• Clinical course and severity of the clinical consequences<br>• number of deaths within the observation period<br>• Pharmacoeconomic implications of ADRs / medication errors<br>
© Copyright 2025. All Rights Reserved by MedPath